SOLITARY THYROID NODULES
Proper management of the solitary thyroid nodule is perhaps the area of greatest controversy among thyroidologists. This controversy continues because it is possible to obtain statistics to support any stand one wishes to take.
One of the major problems in estimating the risk of malignancies in thyroid nodules is to eliminate bias in case selection. We attempted to do this by studying patients with thyroid nodules who were referred for radioisotopic scan of the thyroid gland [1] . Presumably, most physicians would obtain a radioisotopic scan before making any therapeutic decision. There were l030 patients with solitary "cold" thyroid nodules and 68 of these patients came to thyroid surgery. Thyroid carcinoma was found in 18 percent of patients at surgery. Whether case selection occurred to any significant extent in the patients referred to surgery is not clear. However, even if no further malignancies were found, the incidence of thyroid carcinoma in these presumably unselected patients with solitary cold thyroid nodules would be about 9 percent.
Factors Predisposing to Thyroid Cancer
The possibility of malignancy is clearly increased in solitary "cold" thyroid nodules and it is important to obtain further criteria to select those patients most at risk. Sex All forms of thyroid disease are more common in females and this is true of thyroid malignancy as well. However, non-toxic nodular goiter is even more common than malignancy in females than in males. As a consequence, a solitary thyroid nodule occurring in a male is more likely to be malignant than a solitary nodule occurring in a female. 325
Age Estimates have indicated than one-half the thyroid nodules appearing in children may be malignant. The implication is not that thyroid cancer is more common in childhood but, rather, that thyroid nodules in general are uncommon in this age group. Eighty percent of the children with carcinoma of the thyroid who formed the basis of this estimate had a past history of radiation [2, 3] . The chance of malignancy in the thyroid nodule of children needs to be reappraised now that this type of irradiation has been practically discontinued.
In one study of 30 children with solitary thyroid nodules, only four children had a previous history of neck irradiation [4] . Nevertheless, there was still a 40 percent incidence of carcinoma in the series including the four irradiated children. These data would suggest that thyroid carcinoma continues to be a significant risk in children with solitary thyroid nodules. However, in a study of 5,179 school children in Grades 6 through 12, nodularity of the thyroid was found in 93, 1.8 percent [5] . The nodularity represented adolescent goiter in 34 children and thyroiditis in 31. Benign adenomas were found in 20 and only two thyroid cancers were found. The 28 thyroid nodules that proved to be neoplasms were discrete, solitary, of firm consistency, and without changes in the rest of the thyroid. Previous Irradiation of the Head and Neck
Previous irradiation of the head and neck markedly increases the chances of malignancy in a thyroid nodule. The observation in 1950 that nine of twenty-eight children with carcinoma of thyroid had been given radiotherapy to the thymus in infancy first highlighted this association, which was later confirmed in prospective studies [6, 7] . Most instances of thyroid malignancy following neck radiation had been reported within 10 years after radiation therapy. Since this type of radiation therapy to the neck had been virtually discontinued, a degree of complacency developed among many physicians. However, recent reports indicating an increased incidence of thyroid carcinoma, an average of 25 years after radiation exposure to the head and neck, have dispelled this illusion [8] . Despite direct questioning, few patients with a thyroid nodule were able to give a history of radiation during infancy. Public awareness increased dramatically after the relationship was featured in a television drama.
The exact magnitude of the increase in thyroid carcinoma after irradiation to the neck is unknown because appropriate age-matched control data are sparse. However, the increase in thyroid carcinoma is significant, and estimates have ranged from a twofold to a one hundredfold increase in the frequency of thyroid cancer.
PHYSICAL CHARACTERISTICS Careful examination of the thyroid can be extremely helpful in determining the proper degree of suspicion of underlying malignancy. A history of recent thyroid growth, dysphagia, or dyspnea should make the examiner suspicious of malignancy. Palpation of the thyroid should be done carefully with particular attention to the regularity and hardness of the nodule, whether the gland is fixed to surrounding structures and whether there are palpable regional lymph nodes. On the other hand, the presence of a multinodular goiter would decrease the suspicion of malignancy.
A group of patients with thyroid nodules were first classified clinically and these results were compared to the findings at surgery [9] . Thyroid cancer was found in 76 percent of cases thought to be malignant clinically, 12 percent of cases thought to be benign clinically but symptomatic as indicated by pain, recent change in goiter size, or dysphagia and 3 percent of patients thought to be benign and asymptomatic. In this particular study of 53 patients, there were only two patients with thyroid carcinoma who were free of symptoms.
The most important physical sign is the presence of a hard, irregular thyroid nodule. Extreme hardness may be due to hemorrhage into a cyst with subsequent calcification. If the thyroid cancer has spread beyond the capsule and invaded surrounding structures, the clinical diagnosis becomes comparatively simple although Riedel's struma can also extend beyond the gland. Fixation to the strap muscles, trachea, or larynx is easily detected on physical examination. Recurrent laryngeal nerve paralysis is not a common presenting symptom in thyroid carcinoma but does occur.
LABORATORY DIAGNOSIS
The presence of a solitary thyroid nodule raises the question of thyroid malignancy and the above predisposing factors may strengthen or allay suspicions in the individual patient. The next step in the evaluation is to use the laboratory to discriminate which nodules may be malignant and which may be benign. Radioactive Scan of the Thyroid Scanning of the thyroid after the administration of a tracer dose of radioactive iodine or Technetium-99m permits the delineation of functioning and-nonfunctioning areas of the thyroid. Since even well-differentiated thyroid carcinomas do not concentrate iodine as efficiently as normal thyroid, hypofunctioning or "cold" thyroid nodules have been considered to harbor a greater risk of malignancy. This classification is established by assessing the amount of radioactivity within the nodule. The "cold" nodule must be approximately one centimeter in diameter. Large nodules may produce a well-defined focal defect, marginal indentation, or locally reduced parenchymal activity. Demonstration of a "cold" thyroid nodule is significant but unfortunately non-specific. The majority of clinically detectable thyroid nodules are less functional than the extra-nodular thyroid tissue [10] .
Iodine',3' has been the radionuclide most widely used for imaging the thyroid. Although the high absorbed radiation doses were recognized with concern, this concern has heightened with the recurrence of interest in the delayed effects of neck The thyroid gland is not as acoustically dense as the surrounding tissue. Tracheal cartilage represents the most dense structure in the area. In addition to distinguishing between solid and cystic thyroid nodules, enlargement of the thyroid due to tumor growth can be differentiated from enlargement due to cystic or hemorrhagic degeneration [13] .
Cysts have been reported to occur in 20 percent of solitary thyroid nodules [14] . Although the possibility of malignancy is significant, particularly in a partially cystic lesion, the incidence is less than in a solid lesion. The Since the majority of patients who have had a biopsy of the thyroid do not have a subsequent thyroidectomy, comparison of the biopsy specimen with the entire thyroid gland is frequently impossible. In a series of 81 cases where 93 percent of needle biopsy diagnoses were confirmed by thyroid surgery, the errors were due to lymphoma complicating Hashimoto's disease, undifferentiated carcinoma diagnosed as non-specific thyroiditis, and follicular carcinoma mistaken for follicular adenoma [15] . No serious complications occurred with the needle biopsy procedure and in none of the primary cancers was there evidence of tumor implantation in the needle track. However, there was a single example of seeding in a renal cell carcinoma metastatic to the thyroid. If there is a significant clinical suspicion of thyroid cancer, a .negative needle biopsy should not deter immediate surgery and is probably not indicated in such cases.
Thyroid biopsy with a cutting needle has the potential for complications which have made many physicians cautious about the procedure. Aspiration thyroid biopsy with a fine needle obviates the risk of serious complications that may occur with cutting needles like the Vim-Silverman. The amount of tissue obtained is not as great which may make accurate diagnosis more difficult. However, despite the random nature of the sampling, the accuracy of the thyroid cytology has been high [16] . Adequate aspirate for cytologic diagnosis can be obtained in 95 percent of cases and may agree with the histology at surgery in as many as 80 percent of cases.
Nevertheless, the possibility of sampling error is large, and a negative aspiration biopsy should not influence the therapeutic decision.
MANAGEMENT OF THE SOLITARY THYROID NODULE A therapeutic decision must be made about the management of the solitary thyroid nodule, and a decision tree for management is outlined in Fig. 1 The question has been raised about the practice of using thyroid hormone suppression in solitary "cold" nodules with the implication that "cold" means inactive. Actually, "cold" nodules have been shown to be more active biochemically than "warm" nodules [ 17] . They appear to have a defect in iodine trapping but other parameters such as glucose oxidation and cyclic AMP levels are actually increased. ln one study, 50 percent of the "cold" nodules did decrease in size with thyroid hormone therapy [18] . Dose If the patient with a solitary thyroid nodule is to have a trial of thyroid hormone suppression, it is important to know how long thyroid hormone should be administered before deciding that the nodule will not regress with suppression of circulating TSH. Some patients have not had regression in their goiter until the treatment was continued for a year or longer. Half the patients receiving thyroid hormone suppressive therapy for non-toxic goiter had a decrease in the size of their thyroid nodules after three months. When patients who had not responded were treated for another four months, one-third of the nodules decreased in size, and it made no difference whether the dose of thyroid was increased or not. The data suggest a course of therapy for at least three months and preferably six months before deciding that the thyroid nodule will not respond to suppression. Re-evaluation at threemonth intervals would allow a management decision based on factors such as sex and age in addition to response to thyroid hormone.
If the thyroid nodule disappears completely, then thyroid hormone suppression should be continued indefinitely. Regression of the solitary nodule does not rule out cancer but does indicate that the nodule is responsive to TSH. Thyroid hormone should be continued as long as there is no change in the size of the nodule and immediate surgery advised if the nodule should enlarge while on suppressive therapy. If the nodule does not regress completely, then the decision whether or not to operate will depend on the other factors already discussed.
Surgery
If the decision is made to operate, both lobes of the thyroid should be totally exposed even though the nodule is palpable preoperatively in only one lobe. Multiple thyroid nodules are discovered at surgery in as many as 60 percent of cases diagnosed as a single nodule preoperatively by careful palpation and scan. If multinodular goiter is discovered at operation, the risk of carcinoma in the thyroid nodule lessens dramatically but the surgeon should probably go on to remove the lobe thought to contain the single nodule.
